Skip to main content

Markets News Screener Research Editorials Pricing About

⌘K

Sign in Start free

Not investment advice. Moatkeep provides data and educational content, not recommendations.

Financial glossary·Pricing·About·Disclaimer·Terms·Privacy·Cookies·Methodology·Support·Company directory·Companies by industry·Feed

© moatkeep 2026

TRex Bio, Inc. (TRXB) stock — financials, valuation and filings | Moatkeep

Companies/Nasdaq/TRXB

TRex Bio, Inc.

TRXB · Nasdaq

$13.52−6.31%

Close, 2026-10-29Close, 2026-10-29 · source: Databento · USD · figures not investment advice

Window -3.6%vs low +0.1%vs high -12.8%

Pricethrough 2026-10-29ex-date (0) · fiscal quarter (0)

Dividends: company filings (SEC EDGAR) and the historical exchange record.

State of incorporation: DE
Fiscal year end: Dec 31

Valuation & key statistics

Valuation under review.

Financials · latest year

Financial summary not available yet.

Source: SEC EDGAR (XBRL) · figures in USD millions